These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 3021278
1. An octadecaneuropeptide (ODN) derived from diazepam binding inhibitor increases aggressive interactions in mice. Kavaliers M, Hirst M. Brain Res; 1986 Sep 24; 383(1-2):343-9. PubMed ID: 3021278 [Abstract] [Full Text] [Related]
2. Reduction of pentylenetetrazol-induced convulsions by the octadecaneuropeptide ODN. Garcia de Mateos-Verchere J, Leprince J, Tonon MC, Vaudry H, Costentin J. Peptides; 1999 Dec 24; 20(12):1431-6. PubMed ID: 10698118 [Abstract] [Full Text] [Related]
3. Effect of the diazepam-binding inhibitor-derived peptide, octadecaneuropeptide, on food intake in goldfish. Matsuda K, Wada K, Miura T, Maruyama K, Shimakura SI, Uchiyama M, Leprince J, Tonon MC, Vaudry H. Neuroscience; 2007 Dec 05; 150(2):425-32. PubMed ID: 17936516 [Abstract] [Full Text] [Related]
4. The octadecaneuropeptide ODN induces anxiety in rodents: possible involvement of a shorter biologically active fragment. De Mateos-Verchere JG, Leprince J, Tonon MC, Vaudry H, Costentin J. Peptides; 1998 Dec 05; 19(5):841-8. PubMed ID: 9663449 [Abstract] [Full Text] [Related]
5. Involvement of diazepam binding inhibitor and its fragment octadecaneuropeptide in social isolation stress-induced decrease in pentobarbital sleep in mice. Dong E, Matsumoto K, Tohda M, Watanabe H. Life Sci; 1999 Dec 05; 64(19):1779-84. PubMed ID: 10353632 [Abstract] [Full Text] [Related]
6. Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake. do Rego JC, Orta MH, Leprince J, Tonon MC, Vaudry H, Costentin J. Neuropsychopharmacology; 2007 Jul 05; 32(7):1641-8. PubMed ID: 17151595 [Abstract] [Full Text] [Related]
7. Influence of adrenal glands on the modulation of prolactin gene expression by the endogenous benzodiazepine ligand octadecaneuropeptide in the male rat pituitary gland. Wang H, Li S, Givalois L, Pelletier G. J Neuroendocrinol; 1998 Mar 05; 10(3):193-8. PubMed ID: 9576607 [Abstract] [Full Text] [Related]
9. Further studies on the mechanism of action of the endogenous benzodiazepine receptor ligand octadecaneuropeptide on gonadotropin-releasing hormone gene expression in the rat brain. Li S, Pelletier G. Neuroendocrinology; 1996 Aug 05; 64(2):79-84. PubMed ID: 8857601 [Abstract] [Full Text] [Related]
13. Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Ferrero P, Santi MR, Conti-Tronconi B, Costa E, Guidotti A. Proc Natl Acad Sci U S A; 1986 Feb 05; 83(3):827-31. PubMed ID: 3456171 [Abstract] [Full Text] [Related]
14. The octadecaneuropeptide ODN inhibits apomorphine-induced yawning in rats. Garcia de Mateos-Verchere J, Leprince J, Tonon MC, Vaudry H, Costentin J. Eur J Pharmacol; 1998 Sep 18; 357(2-3):121-6. PubMed ID: 9797027 [Abstract] [Full Text] [Related]
15. The stimulatory effect of the octadecaneuropeptide (ODN) on cytosolic Ca2+ in rat astrocytes is not mediated through classical benzodiazepine receptors. Gandolfo P, Patte C, Leprince J, Thoumas JL, Vaudry H, Tonon MC. Eur J Pharmacol; 1997 Mar 19; 322(2-3):275-81. PubMed ID: 9098698 [Abstract] [Full Text] [Related]
16. Detection, characterization and biological activities of [bisphospho-thr3,9]ODN, an endogenous molecular form of ODN released by astrocytes. Gach K, Belkacemi O, Lefranc B, Perlikowski P, Masson J, Walet-Balieu ML, Do-Rego JC, Galas L, Schapman D, Lamtahri R, Tonon MC, Vaudry D, Chuquet J, Leprince J. Neuroscience; 2015 Apr 02; 290():472-84. PubMed ID: 25639232 [Abstract] [Full Text] [Related]
17. Inhibitory influences of the adrenal steroid, 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone [correction of tetrahydroxycorticosterone] on aggression and defeat-induced analgesia in mice. Kavaliers M. Psychopharmacology (Berl); 1988 Apr 02; 95(4):488-92. PubMed ID: 3145520 [Abstract] [Full Text] [Related]